Skip to main content

Table 4 Clinical cure rates by diagnosis at test-of-cure visit (ME population)

From: Efficacy and safety of tigecycline monotherapy vs. imipenem/cilastatin in Chinese patients with complicated intra-abdominal infections: a randomized controlled trial

  Tigecycline Imipenem/cilastatin Difference (Tigecycline-Imipenem/cilastatin)
Diagnosis N % (95% CI) N % (95% CI) % (95% CI)
Complicated appendicitis 40/46 87.0
(73.7, 95.1)
45/45 100
(92.1, 100.0)
-13.0
(-27.0, -0.6)
Complicated cholecystitis 2/2 100.0
(15.8, 100.0)
0/0 NA NA
Peritonitis 2/3 66.7
(9.4, 99.2)
2/3 66.7
(9.4, 99.2)
0.0
(-62.7, 62.7)
Gastric/duodenal perforation 1/1 100.0
(2.5, 100.0)
0/0 NA NA
  1. NA - not available